The Glymphatic System: From Basic Research Advances to Non-Invasive Brain Stimulation Applications-A Narrative Review
Journal of Integrative Neuroscience · 16.10.2026 · 25 (10)
DOI: 10.31083/jin50308 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Integrative Neuroscience, online erschienen am 16.10.2026. Verfasst von Zongcheng Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Affiliated Hospital of Zunyi Medical University, 563100 Zunyi, Guizhou, China. Hauptthemen laut MEDLINE: Glymphatic System, Transcranial Magnetic Stimulation. Die Arbeit nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Famous Clinical Doctor Program of the Zunyi Medical University, Basic Research Program of Guizhou Province, general project, Qian Science and Technology Foundation.
Abstract (Originalsprache)
The glymphatic system (GS) is a pathway for waste clearance in the brain and a promising therapeutic target for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). GS function is governed by multiple interacting factors, such as aquaporin-4 (AQP4) polarization, cerebral arterial pulsatility, and the integrity of meningeal lymphatic vessels (MLVs). Despite growing recognition of the importance of the GS, effective strategies to actively and non-invasively enhance glymphatic function have long been lacking. In recent years, non-invasive neuromodulatory approaches—most notably focused ultrasound (FUS), repetitive transcranial magnetic stimulation (rTMS), and transcranial photobiomodulation (tPBM)—have emerged as novel strategies to modulate GS activity. Growing evidence suggests that these interventions can enhance glymphatic transport by influencing key regulatory mechanisms, including cerebrovascular dynamics, AQP4 expression and localization, and meningeal lymphatic drainage. In this review, we summarize current experimental advances in non-invasive, external alterations of the GS, discuss underlying mechanisms and translational challenges, and highlight the therapeutic potential of GS modulation in neurological diseases characterized by impaired waste clearance. However, further research about the function and dysfunction of the GS in humans is needed to evaluate the findings from animal studies and thereby fill the translational gap in the human pathophysiology of the GS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology, Affiliated Hospital of Zunyi Medical University, 563100 Zunyi, Guizhou, China.
- Key Laboratory of Anesthesia and Organ Protection of Ministry of Education (In Cultivation), Zunyi Medical University, 563100 Zunyi, Guizhou, China.
Förderung
- National Natural Science Foundation of China
- Famous Clinical Doctor Program of the Zunyi Medical University
- Basic Research Program of Guizhou Province, general project, Qian Science and Technology Foundation
- Key Project of Zunyi City Science and Technology Plan (Technology Cooperation), Zun City Science and Technology Foundation
Zitieren
APA
Jiang, Z., Yue, W., Zhang, Y., Yu, S., Wang, H., & Luo, T. (2026). The Glymphatic System: From Basic Research Advances to Non-Invasive Brain Stimulation Applications-A Narrative Review. Journal of Integrative Neuroscience, 25(10). https://doi.org/10.31083/jin50308
Vancouver
Jiang Z, Yue W, Zhang Y, Yu S, Wang H, Luo T. The Glymphatic System: From Basic Research Advances to Non-Invasive Brain Stimulation Applications-A Narrative Review. Journal of Integrative Neuroscience. 2026;25(10). doi:10.31083/jin50308
BibTeX
@article{Jiang2026,
author = {Jiang, Zongcheng and Yue, Wei and Zhang, Yuqian and Yu, Shouyang and Wang, Haiying and Luo, Tianyuan},
title = {The Glymphatic System: From Basic Research Advances to Non-Invasive Brain Stimulation Applications-A Narrative Review},
journal = {Journal of Integrative Neuroscience},
year = {2026},
volume = {25},
number = {10},
doi = {10.31083/jin50308}
}
EUVIMED